DR. ANDREW MENA SHAROBEEM D.O. NPI 1629389382

NPI Details

DR. Andrew Mena Sharobeem, D.O. is a rheumatology internal medicine in Glendale, AZ with 16 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Andrew Mena Sharobeem, D.O. NPI is 1629389382. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: NEW YORK COLLEGE OF OSTEO MEDICINE OF NEW YORK INSTITUTE OF TECHNOLOGY
Graduation Year:2010

The provider's business location address is:

5681 W BEVERLY LN STE 100
GLENDALE, AZ
ZIP 85306-800
Phone: (480) 443-8400
Fax: (480) 443-8697

The NPI 1629389382 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Analysis for antibody to coccidioides (bacteria) (HCPCS:86635)
• Vitamin d-3 level (HCPCS:82306)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Hepatitis b core antibody (igm) measurement (HCPCS:86705)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Injection, methylprednisolone acetate, 20 mg (HCPCS:J1020)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Hepatitis c antibody measurement (HCPCS:86803)
• Complete ultrasound scan of joint (HCPCS:76881)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Tuberculosis test, gamma interferon (HCPCS:86480)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment (HCPCS:77085)
• Uric acid level, blood (HCPCS:84550)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection of trigger points, 3 or more muscles (HCPCS:20553)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Total protein level, urine (HCPCS:84156)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Injection into tendon or ligament (HCPCS:20550)
• Ferritin (blood protein) level (HCPCS:82728)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Rheumatoid factor level (HCPCS:86431)
• Phosphate level (HCPCS:84100)
• Urinalysis, manual test (HCPCS:81002)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Magnesium level (HCPCS:83735)
• Ultrasound scan of head and neck soft tissue (HCPCS:76536)

The enumeration date for this NPI number is 6/28/2010 and was last updated on 8/19/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.